Processa Pharmaceuticals (PCSA) Income from Discontinued Operations (2015 - 2016)
Processa Pharmaceuticals' (PCSA) quarterly Income from Discontinued Operations came in at -$17.0 in Q4 2016, up 99.95% on a YoY basis from -$8.5 in Q1 2016, and up 59.52% quarter-over-quarter from -$42.0 in Q3 2016.
Powered by 
Analysis
Processa Pharmaceuticals (PCSA) Income from Discontinued Operations (2015 - 2016) Analysis & Trends
Processa Pharmaceuticals (PCSA) has reported Income from Discontinued Operations for 2 consecutive years, with -$17.0 the latest figure, recorded in Q4 2016.
- For the quarter ending Q4 2016, Income from Discontinued Operations rose 99.95% year-over-year to -$17.0; the trailing twelve-month figure through Dec 2016 stood at $1197.0 (up 100.32% YoY), and the FY2016 full-year result was $1197.0, up 100.32% from the prior year.
- Income from Discontinued Operations improved to -$17.0 in Q4 2016 per PCSA's latest filing, from -$42.0 in the prior quarter.
- Across five years, Income from Discontinued Operations topped out at $3260.0 in Q2 2016 and bottomed at -$152180.0 in Q1 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | - |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | - |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | - |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 8.00 Mn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | - |
| 10 | Processa Pharmaceuticals | 5.75 Mn | 5.75 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2016 | -17.00 |
| Sep 30, 2016 | -42.00 |
| Jun 30, 2016 | 3,260.00 |
| Mar 31, 2016 | -2,004.00 |
| Dec 31, 2015 | -34,319.00 |
| Sep 30, 2015 | -72,359.00 |
| Jun 30, 2015 | -111,448.00 |
| Mar 31, 2015 | -152,180.00 |